Profil
Diego A.
Rey was the Chief Technology Officer of GeneWeave Biosciences, Inc. which was founded in 2007.
Mr. Rey is also the founder of Endpoint Health, Inc.
Aktive Positionen von Diego A. Rey
| Unternehmen | Position | Beginn |
|---|---|---|
Endpoint Health, Inc.
 Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Endpoint Health, Inc. is a medicine company. The firm?s novel approach combines proprietary biomarkers and patient data with diagnostics and artificial intelligence to guide therapy choice and improve patient outcomes. The company is headquartered in Palo Alto, CA. | Gründer | - |
Ehemalige bekannte Positionen von Diego A. Rey
| Unternehmen | Position | Ende |
|---|---|---|
GeneWeave Biosciences, Inc.
 GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
GeneWeave Biosciences, Inc.
GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Health Services |
Endpoint Health, Inc.
Endpoint Health, Inc. Miscellaneous Commercial ServicesCommercial Services Endpoint Health, Inc. is a medicine company. The firm?s novel approach combines proprietary biomarkers and patient data with diagnostics and artificial intelligence to guide therapy choice and improve patient outcomes. The company is headquartered in Palo Alto, CA. | Commercial Services |
